Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer Research|July 29, 2010
Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinasesJennifer M Atkinson, Robert A Falconer, Dylan R Edwards, et al.
Molecular Cancer Therapeutics|December 10, 2009
In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenograftsKaye J Williams, Mark R Albertella, Brian Fitzpatrick, et al.
Molecular Cancer Therapeutics|June 19, 2003
Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug developmentPaul Gibson, Jason H Gill, Parveen A Khan, et al.
Lancet (London, England)|November 24, 2018
Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trialMark A Hull, Kirsty Sprange, Trish Hepburn, et al.
International Journal of Oncology|September 18, 2004
NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin CSaurajyoti Basu, John E Brown, G Michael Flannigan, et al.
International Journal of Cancer|March 5, 2004
Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapySaurajyoti Basu, John E Brown, G Michael Flannigan, et al.
RSC Medicinal Chemistry|September 16, 2024
Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonistsAdam Throup, Manar Saleh Zraikat, Andrew Gordon, et al.
Molecular Cancer Therapeutics|October 4, 2012
Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladderMark Sutherland, Jason H Gill, Paul M Loadman, et al.
Gut|September 28, 2017
A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiotaHenry Watson, Suparna Mitra, Fiona C Croden, et al.
Scientific Reports|September 24, 2021
Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancerDaniela Presa, Syed A Khurram, Amir Z A Zubir, et al.
Pageof 8